title: Metabolism and testicular toxicity of 1,3-dinitrobenzene in the rat: effect of route of administration.
abstract: Studies investigating the testicular toxicity of 1,3-dinitrobenzene (1,3-DNB) have utilized both the oral (po) and intraperitoneal (ip) routes of administration. These two administration routes could be expected to produce different pharmacokinetic profiles and, potentially, different degrees of toxicity. In the present work, the effect of route of administration upon 1,3-DNB disposition and susceptibility to testicular damage has been investigated. Male Sprague-Dawley rats were given 25 mg/kg 1,3-DNB either ip or po. Metabolites were quantitated in blood, urine, and feces, and methemoglobin levels were determined. Peak blood levels of 1,3-DNB and its major metabolite were three times higher in ip-dosed rats than in po-dosed rats. While the lower blood levels seen after po administration were maintained for greater than 6 hr, blood levels fell rapidly after ip dosing, reaching po levels at 6 hr postadministration. Peak methemoglobin levels in ip-dosed animals were twice that of po-dosed animals. Route of administration had a minor effect on the levels of urinary metabolites, while there was a significantly higher excretion of metabolites in the feces of po-dosed animals. Despite the markedly higher 1,3-DNB blood levels after ip administration, there were only subtle differences in testicular damage. The data raise the possibility that above a threshold level of 1,3-DNB in the blood, only the duration of testicular exposure to the toxicant may govern susceptibility to testicular toxicity.
authors.affiliation: Department of Environmental Toxicology, University of California at Davis 95616-8588, USA.
authors.forename: S F
authors.initials: SF
authors.lastname: McEuen
authors.forename: C F
authors.initials: CF
authors.lastname: Jacobson
authors.forename: C D
authors.initials: CD
authors.lastname: Brown
authors.forename: M G
authors.initials: MG
authors.lastname: Miller
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001711:Biotransformation; D004136:Dinitrobenzenes / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity*; D007274:Injections, Intraperitoneal; D008297:Male; D008706:Methemoglobin / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013733:Testicular Diseases / Q000139:chemically induced* / Q000473:pathology; D013737:Testis / Q000473:pathology; D014018:Tissue Distribution
chemical_list: D004136:Dinitrobenzenes; D008706:Methemoglobin; C017906:3-dinitrobenzene